These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7093119)

  • 1. Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.
    Babbage JW; Berenbaum MC
    Br J Cancer; 1982 Jun; 45(6):830-4. PubMed ID: 7093119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
    Valeriote F; Grates H
    J Natl Cancer Inst; 1986 Jan; 76(1):61-5. PubMed ID: 3455743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity of N-phenyl-1-naphthylamine and N-phenyl-2-naphthylamine in mice.
    Wang HW; Wang D; Dzeng RW
    Cancer Res; 1984 Jul; 44(7):3098-100. PubMed ID: 6327034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of age of host on the chemotherapy of murine myeloma LCP-1.
    Teller MN; Bowie M; Mountain IM
    J Gerontol; 1974 Jul; 29(4):360-5. PubMed ID: 4833754
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
    Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Naphthalenediamine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():127-32. PubMed ID: 7049899
    [No Abstract]   [Full Text] [Related]  

  • 7. Phospholipid composition of small unilamellar liposomes containing melphalan influences drug action in mice bearing PC6 tumours.
    Large P; Gregoriadis G
    Biochem Pharmacol; 1983 Apr; 32(7):1315-8. PubMed ID: 6847720
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
    Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
    Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
    Ritter C; Iyengar CL; Rutman RJ
    Cancer Res; 1981 Jun; 41(6):2366-71. PubMed ID: 7237434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
    Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
    Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
    [No Abstract]   [Full Text] [Related]  

  • 12. The cyclic use of multiple alkylating agents in multiple myeloma.
    Harley JB; Ramanan SV; Kim I; Thiagarajan PV; Chen JH; Gomez R; Koppel D; Hyde F; Gustke S; Krall J
    W V Med J; 1972 Jan; 68(1):1-3. PubMed ID: 4500402
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled dose-finding study with sertraline.
    Amin M; Lehmann H; Mirmiran J
    Psychopharmacol Bull; 1989; 25(2):164-7. PubMed ID: 2690162
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
    Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
    Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local anesthetic activity and acute toxicity of N-heptyl-1,2,3,4-tetrahydro-6-methoxy-1-naphthylamine methanesulfonate.
    Bopp BA; Dren AT; Ebert DM; Geiszler AO
    J Pharm Sci; 1978 Jun; 67(6):882-4. PubMed ID: 660484
    [No Abstract]   [Full Text] [Related]  

  • 17. A new substance effective against transplantable tumors in vivo: L-cystine-bis-(N,N-beta-chloroethyl)-hydrazide.
    Golovinsky EV; Alexiev BV; Spassov AV; Stoev SB; Emanuilov EA; Angelov II; Maneva LS; Stoychev TS
    Neoplasma; 1977; 24(4):401-4. PubMed ID: 904741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.
    Ghanta VK; Jones MT; Woodard DA; Durant JR; Hiramoto RN
    Cancer Res; 1977 Mar; 37(3):771-4. PubMed ID: 851480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of liposome-incorporated streptomycin in experimental tuberculosis in mice].
    Vladimirskiĭ MA; Ladygina GA; Tentsova AI
    Antibiotiki; 1983 Jan; 28(1):23-6. PubMed ID: 6830199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.